Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters

Journal of Gene Medicine

Volumn 7, Issue 9, 2005, Pages 1158-1171

  Dupuy, Franck P ^a   Mouly, Enguerran ^a   Mesel Lemoine, Mariana ^a   Morel, Céline ^a   Abriol, Julien ^a   Cherai, Mustapha ^a   Baillou, Claude ^a   Nègre, Didier ^b   Cosset, François Loïc ^b   Klatzmann, David ^a   Lemoine, François M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

Bicistronic lentiviral vectors; CD34+ cells; Dendritic cells; Monocytes; Promoters; T lymphocytes

Indexed keywords

ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; THYMIDINE;

ARTICLE; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; DENDRITIC CELL; FLOW CYTOMETRY; GENE CASSETTE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HEPATITIS VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RIBOSOME; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TARGET CELL;

ANTIGENS, CD34; ANTIGENS, THY-1; DENDRITIC CELLS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LENTIVIRUS; PROMOTER REGIONS (GENETICS); SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSFECTION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS; WOODCHUCK HEPATITIS B VIRUS;

EID: 25144463109     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.769     Document Type: Article

References (50)

1. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40.
2. Buchschacher GL Jr, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95: 2499-2504.
3. Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000; 2: 308-316.
4. Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
5. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
6. Miyoshi H, Blomer U, Takahashi M, et al. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-8157.
7. Sirven A, Pflumio F, Zennou V, et al. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 2000; 96: 4103-4110.
8. Follenzi A, Ailles LE, Bakovic S, et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25: 217-222.
9. Ramezani A, Hawley TS, Hawley RG. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2000; 2: 458-469.
10. Salmon P, Kindler V, Ducrey O, et al. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000; 96: 3392-3398.
11. Zufferey R, Donello JE, Trono D, et al. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886-2892.
12. Negre D, Duisit G, Mangeot PE, et al. Lentiviral vectors derived from simian immunodeficiency virus. Curr Topics Microbiol Immunol 2002; 261: 53-74.
13. Mangeot PE, Duperrier K, Negre D, et al. High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 2002; 5: 283-290.
14. Miyoshi H, Smith KA, Mosier DE, et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.
15. Sirven A, Ravet E, Charneau P, et al. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001; 3: 438-448.
16. Chinnasamy D, Chinnasamy N, Enriquez MJ, et al. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 2000; 96: 1309-1316.
17. Dardalhon V, Herpers B, Noraz N, et al. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther 2001; 8: 190-198.
18. Zhou X, Cui Y, Huang X, et al. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells. Hum Gene Ther 2003; 14: 1089-1105.
19. Cavalieri S, Cazzaniga S, Geuna M, et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 2003; 102: 497-505.
20. Unutmaz D, KewalRamani VN, Marmon S, et al. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 1999; 189: 1735-1746.
21. Firat H, Zennou V, Garcia-Pons F, et al. Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med 2002; 4: 38-45.
22. Chinnasamy N, Chinnasamy D, Toso JF, et al. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum Gene Ther 2000; 11: 1901-1909.
23. Salmon P, Arrighi JF, Piguet V, et al. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells. J Gene Med 2001; 3: 311-320.
24. Oki M, Ando K, Hagihara M, et al. Efficient lentiviral transduction of human cord blood CD34(+) cells followed by their expansion and differentiation into dendritic cells. Exp Hematol 2001; 29: 1210-1217.
25. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 193-194.
26. de Felipe P. Polycistronic viral vectors. Curr Gene Ther 2002; 2: 355-378.
27. Reiser J, Lai Z, Zhang XY, et al. Development of multigene and regulated lentivirus vectors. J Virol 2000; 74: 10 589-10 599.
28. Zhu Y, Feuer G, Day SL, et al. Multigene lentiviral vectors based on differential splicing and translational control. Mol Ther 2001; 4: 375-382.
29. Zhu Y, Planelles V. A multigene lentiviral vector system based on differential splicing. Methods Mol Med 2003; 76: 433-448.
30. Yu X, Zhan X, D'Costa J, et al. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther 2003; 7: 827-838.
31. Gallardo HF, Tan C, Sadelain M. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Ther 1997; 4: 1115-1119.
32. Richard E, Geronimi F, Lalanne M, et al. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines. J Gene Med 2003; 5: 737-747.
33. Esslinger C, Romero P, MacDonald HR. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum Gene Ther 2002; 13: 1091-1100.
34. Lemoine FM, Mesel-Lemoine M, Cherai M, et al. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line. J Gene Med 2004; 6: 374-386.
35. Movassagh M, Baillou C, Cosset FL, et al. High level of retrovirus-mediated gene transfer into dendritic cells derived from cord blood and mobilized peripheral blood CD34+ cells. Hum Gene Ther 1999; 10: 175-187.
36. Movassagh M, Boyer O, Burland MC, et al. Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum Gene Ther 2000; 11: 1189-1200.
37. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
38. Lansdorp PM. CDw90 cluster workshop report. In Leukocyte Typing V, Schlossman SF, Boumsell L, Gilks W, et al. (eds). Oxford University Press: Oxford: 1995; 967-968.
39. Craig W, Kay R, Cutler RL, et al. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331-1342.
40. Negre D, Mangeot PE, Duisit G, et al. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 2000; 7: 1613-1623.
41. Chapuis F, Rosenzwajg M, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997; 27: 431-441.
42. Mizuguchi H, Xu Z, Ishii-Watabe A, et al. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000; 1: 376-382.
43. Lopez de Quinto S, Martinez-Salas E. Parameters influencing translational efficiency in aphthovirus IRES-based bicistronic expression vectors. Gene 1998; 217: 51-56.
44. Pozner A, Goldenberg D, Negreanu V, et al. Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms. Mol Cell Biol 2000; 20: 2297-2307.
45. Lindemann C, Schilz AJ, Emons B, et al. Down-regulation of retroviral transgene expression during differentiation of progenitor-derived dendritic cells. Exp Hematol 2002; 30: 150-157.
46. Gallardo HF, Tan C, Ory D, et al. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 1997; 90: 52-57.
47. Haas DL, Case SS, Crooks GM, et al. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther 2000; 2: 71-80.
48. Sandrin V, Boson B, Salmon P, et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002; 100: 823-832.
49. Emery DW, Yannaki E, Tubb J, et al. A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A 2000; 97: 9150-9155.
50. Lipps HJ, Jenke AC, Nehlsen K, et al. Chromosome-based vectors for gene therapy. Gene 2003; 304: 23-33.